Diabetes: Drug-Disease Interactions
Many types of commonly prescribed drugs can have desirable or undesirable effects on blood glucose levels. A drug-disease or pharmacodynamic interaction is defined as a desirable or undesirable alteration of blood glucose level by a drug prescribed for a purpose other than its glycemic effect. This interaction has an intrinsic physiologic effect. A list of specific drug-disease and drug-drug interactions for commonly prescribed drugs is included in Table 5.1, Module C, of the Athena Forum Diabetes Course.
Diabetes: Module C, Pharmacologics
Announcing New Course - MCO Continuum
The following new course (300 + pages) will be added to our Athena Forum curriculum by Thanksgiving. All courses are designed to improve organizational performance in patient care, staff competencies and claims management.
Module A: Prior-Auth
Module B: Concurrent Review
Module C: Transitions in Care
|Announcing New Course - EOL & Palliative Care
The following new course (300 + pages) will be added to our Athena Forum curriculum by Christmas. All courses are designed to improve organizational performance in patient care, staff competencies and claims management.
EOL & Palliative Care
Mod A: The Evolving Role of EOL & Palliative Care
Mod B: Patient Goals & Care Planning
Mod C: Symptom Management
Mod D: Regulations & Reimbursements
Mod E: Case Manager's Role in EOL & Palliative Care
First New Lupus Drug in 50 Years Approved by FDA
Over the past 12 months, the U.S. Food and Drug Administration approved 35 new medicines. This is among the highest number of approvals in the past decade, surpassed only by 2009 (37). Many of the drugs are important advances for patients, including: two new treatments for hepatitis C; a drug for late-stage prostate cancer; the first new drug for Hodgkin’s lymphoma in 30 years; and the first new drug for lupus in 50 years. [U.S Food and Drug Administration (FDA) 11/3/2011.]
Memo Archive Did you miss an issue?
Need to look up a reference in a past Monday Memo? All past issues
are archived for your use.
JSPH & Athena Forum – Partners in Chronic Care
Master's Degree in
Chronic Care Management
Managing chronic illness is the key to true healthcare reform.
No matter what its appearance – diabetes, hypertension, arthritis, cardiovascular disease, asthma, cancer or COPD – chronic disease is the greatest contributor to the cost of healthcare in the United States.
The Jefferson School of Population Health's online Master of Science in Chronic Care Management (MS-CCM) stresses chronic illness prevention and wellness, integrates evidence-based guidelines, includes behavioral health concerns, and appreciates cultural and individual variation.
The program prepares leaders to critically analyze, design, implement and evaluate systems to improve chronic illness prevention and care management across various health care settings and populations.
For more information about Jefferson's MS-CCM program, click here. 215-503-5305
CM Excellence® Series:
» Principles of Case
» Patient Advocacy
» Utilization Management
» Discharge Planning
» Hospital Revenue Cycle
» Behavioral Health
» Colorectal Cancer
» CV Risk: Stroke & MI
» EOL & Palliative
» GI Disorders
» Heart Failure
» Multiple Sclerosis
» Obesity Management
» Pain Management
» Rheumatoid Arthritis
» Women’s Health
You have received this e-mail because you are a subscriber
to Athena Forum. If you wish to be excluded from any future
Monday Memos, please send email to the registrar.
Please put the word unsubscribe in the subject line.